Kidney Disease and Environmental Exposures: Lead, Cadmium, and PFAS

The kidney's function — filtering approximately 200 litres of blood per day, concentrating waste into 1–2 litres of urine — makes it one of the most chemically exposed organs in the body. Compounds that are filtered by the kidney reach concentrations in the tubular cells that can far exceed their plasma levels, and metals and other charged compounds can accumulate in renal tissue over decades of low-level exposure.

This concentration mechanism helps explain why lead and cadmium — two heavy metals whose environmental exposure has been largely normalised in public discourse — are nephrotoxins at levels well within the range found in the general population. It also explains why chronic kidney disease has an environmental aetiology that is substantially underrecognised: many patients with progressive kidney function decline, particularly older adults, carry a lifetime of low-level heavy metal accumulation that contributes to that decline without ever generating the acute toxicity that draws clinical attention.

The kidneys don't complain early. They have enormous reserve capacity, and GFR (glomerular filtration rate) can decline significantly before symptoms appear. By the time chronic kidney disease is clinically apparent, a decade or more of subclinical decline has often already occurred — decline that began, in many cases, with exposures from a lifetime before.

Cadmium is one of the most thoroughly studied environmental nephrotoxins — and one of the most compelling examples of a pollutant causing disease at concentrations widely distributed in the general population.

The tubular damage mechanism Cadmium accumulates preferentially in the proximal tubular cells of the kidney. It's absorbed from the gut (dietary exposure from contaminated soil) and the lung (smoking is the largest single exposure source; cadmium is a significant tobacco constituent). Once absorbed, cadmium has an extremely long biological half-life — 10–30 years in the kidney. It accumulates across decades, and at sufficient tissue concentrations it damages tubular cell mitochondria and triggers apoptosis.

Itai-itai disease: the high-dose lesson The most dramatic demonstration of cadmium nephrotoxicity comes from mid-20th century Japan, where rice paddies irrigated with water from a cadmium-contaminated river produced a disease of severe bone pain, kidney failure, and multiple fractures in residents who consumed the rice for decades. The name itai-itai means "it hurts it hurts." It was not an occupational disease — it was caused by dietary cadmium in ordinary food.

The low-dose question in the general population Studies using NHANES data and urinary cadmium measurements in the general US population find dose-dependent associations between urinary cadmium and kidney damage markers (beta-2-microglobulin, N-acetyl-beta-glucosaminidase) at concentrations found in non-smoking Americans — levels far below the threshold previously considered clinically significant. A 2009 study by Järup and Åkesson concluded that kidney damage can occur at urinary cadmium levels previously considered safe.

Lead similarly accumulates in the kidney and contributes to tubular dysfunction and reduced GFR — effects documented in longitudinal studies at blood lead levels below the current reference value.

The association between PFAS exposure and kidney cancer is one of the more concerning recent findings in the PFAS health literature.

The C8 Science Panel findings The C8 Health Panel — independent scientists reviewing the health data from the Parkersburg PFAS contamination — found "probable links" between PFOA exposure and kidney cancer, in addition to testicular cancer, thyroid disease, ulcerative colitis, high cholesterol, and pregnancy-induced hypertension. "Probable link" in C8 panel terminology means: the weight of evidence supports a causal connection.

A 2020 meta-analysis in Environmental Health examined 20 studies and found a significant association between occupational and environmental PFOA exposure and kidney cancer risk, with a dose-response relationship across exposure levels.

The accumulation mechanism PFAS accumulate in blood serum (bound to albumin) rather than in fat, which distinguishes them from many other POPs. The kidney filters serum continuously, and PFAS undergo complex tubular secretion and reabsorption processes that expose tubular cells to sustained PFAS concentrations. Proposed mechanisms for kidney cancer include activation of PPAR-alpha (a transcription factor involved in cell proliferation), immune suppression, and direct effects on tubular cell signalling.

The broader PFAS-kidney relationship Beyond cancer, PFAS exposure is associated with reduced kidney function in epidemiological studies — lower eGFR and higher creatinine in people with higher PFAS blood levels. A 2020 study found that PFAS levels in adolescents predicted kidney function 10 years later, suggesting early exposure has lasting renal consequences.

For people with significant heavy metal or PFAS exposure history, periodic kidney function monitoring is among the most clinically justified uses of the environmental health conversation with a physician.

Standard kidney function tests: • Serum creatinine and eGFR: The most commonly used kidney function measures. GFR below 60 mL/min/1.73m² on two measurements 3 months apart defines CKD. The limitation: these tests don't detect early tubular damage before GFR is affected. • Urinary albumin-to-creatinine ratio: Microalbuminuria (small but elevated urinary albumin) is an early marker of kidney injury that precedes GFR decline. More sensitive for early detection. • Urinary tubular damage markers: Beta-2-microglobulin and N-acetyl-beta-glucosaminidase are research markers of tubular cell injury — the specific damage produced by cadmium and lead. Not standard clinical tests, but available and appropriate in high-exposure individuals.

The conversation to have: For anyone with: • Significant occupational cadmium or lead exposure history (mining, battery manufacturing, smelting, construction in pre-1978 buildings) • Heavy smoking history (a major source of cadmium) • High PFAS water exposure history (documented contaminated water system for a decade or more)

The relevant clinical question is: given this exposure history, should I have more frequent kidney function monitoring, starting at an earlier age than standard recommendations suggest?

PollutionProfile's Historical Exposure Recorder documents the specific exposures and durations that a nephrologist needs to contextualise this question appropriately.